Biomarkers and Cardiovascular Risk StratificationExtensive research reports that biomarkers may be helpful in the assessment of thromboembolic and bleeding risk in patients with atrial fibrillation. At the same time, increasing evidence suggests their role in personalized medicine and in prediction of clinical outcomes in heart failure